Fenethylline

Fenethylline, also spelled fenetylline and widely known by the former brand name Captagon, is a synthetic stimulant that combines structural features of amphetamine and theophylline. It was developed as a pharmaceutical medicine in the 1960s and was used for conditions including attention-deficit disorders and narcolepsy. The name Captagon is now also used for illicit tablets, but many tablets sold under that name today do not contain fenethylline.

History and medical use

Fenethylline was first synthesised by the German company Degussa in 1961. It was marketed as a central nervous system stimulant and was regarded at the time as a possible alternative to amphetamine, partly because early clinical observations suggested a milder effect on blood pressure. It was prescribed for hyperactivity and attention-related disorders, and was also used in some cases of narcolepsy.

The medicine was sold under brand names including Captagon, Biocapton and Fitton. Its medical use declined as concerns about misuse and dependence grew. Fenethylline was brought under international control in the 1980s, and the original pharmaceutical product disappeared from legitimate markets in most countries.

Chemistry

Fenethylline is unusual because it links an amphetamine structure to a theophylline molecule through an ethyl chain. The two components are covalently connected, making fenethylline a codrug rather than a simple mixture of amphetamine and theophylline.

The distinction matters when describing its pharmacology. Although metabolism produces amphetamine and theophylline, the parent compound has its own activity. It is therefore inaccurate to treat fenethylline as nothing more than a tablet containing those two substances.

Pharmacology and metabolism

Fenethylline and its metabolites contribute to stimulant activity. Theophylline is a xanthine compound related to caffeine, while amphetamine acts on monoamine signalling. The combination gives fenethylline a pharmacological profile that differs from that of amphetamine alone.

A detailed study of its pharmacology and metabolism found that only part of the amphetamine theoretically available in the molecule was released. The authors also reported that the drug’s pharmacodynamic activity tracked the concentration of the parent compound in plasma more closely than the amount of amphetamine produced (Nickel and colleagues, 1986).

Later summaries commonly describe amphetamine and theophylline as important metabolites. A report by the European Monitoring Centre for Drugs and Drug Addiction explains that the original Captagon medicine contained 50 mg of fenethylline and that metabolism produces both substances (EMCDDA, 2023).

Subjective effects

The effects described in the PsychonautWiki fenethylline profile are based on a limited set of user reports. Historical medical use provides a separate source of information, but it should not be confused with descriptions of non-medical exposure.

Physical effects

Stimulation and increased wakefulness are among the reported effects. Other accounts mention improved stamina, bronchodilation and reduced appetite. Dry mouth, increased body temperature, muscle cramps and anxiety are also listed.

Some reports describe an abnormal heartbeat or an increase in blood pressure. Historical pharmacological work suggested that the blood-pressure response could differ from that of amphetamine alone, but this does not mean that cardiovascular effects are absent.

Cognitive effects

Reported mental effects include cognitive euphoria, wakefulness and irritability. The available descriptions are relatively brief, and there are too few user reports for a detailed account of changes in attention, mood or perception.

After-effects

Reported after-effects include low mood, irritability and reduced motivation. The evidence is limited, and the duration or frequency of these symptoms has not been established.

Toxicity and the modern Captagon market

The safety profile of pharmaceutical fenethylline cannot be used to assess illicit tablets sold today as Captagon. Chemical analyses of contemporary seizures have frequently found amphetamine and other substances rather than the original pharmaceutical ingredient. The tablets may also contain adulterants, and their composition can vary between batches.

The EMCDDA’s report on Captagon trafficking distinguishes the former medicinal product from the modern illicit market. It describes how the Captagon name continued to be used for tablets that may contain amphetamine and other compounds, making the street name an unreliable indication of chemical contents. This distinction is essential when interpreting reports of poisoning or dependence attributed to “Captagon”.

Fenethylline itself has a longer medical history than most designer stimulants in this group, but its long-term effects are not fully covered by the available modern literature. The pharmacokinetic findings from older studies remain relevant, while current illicit-market products require separate forensic analysis.

Related compounds

Fenethylline is related to amphetamine through one part of its structure and to theophylline through the other. It is sometimes discussed alongside other amphetamine-type stimulants, but its linked molecular structure and metabolism distinguish it from a simple amphetamine formulation.